Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 49 of 49 opportunities
The Thermal Solids Mass Flow-meter was developed with the aim of providing a direct measure of the mass flow rate of solids in a two-phase solids-gas flow regime, specifically for pneumatic transfer applications. The ability to make such measurements could lead to significant efficiency improvements...
These unique antigens could offer a highly effective way to treat or prevent severe malaria through development of drugs or vaccines.
OSCAR™ is a gene amplification system with the potential to simplify the method of protein production in cultured mammalian cells.
A more efficient and lower cost method for synthesis of triphosphates using a polymer-supported reagent that eliminates many of the processing stages of other systems generating far greater yields and higher purity material.
A new generation of broad-spectrum anti-influenza peptides with the scope to treat, as well as prevent, flu and a wider range of clinically relevant viral infections. These peptides have a novel mechanism of action, making them less likely to induce viral resistance and very effective at combatting ...
New methods for cleaning surgical instruments that completely remove protein contamination, including prions – the infectious agents that cause Creutzfeldt-Jakob Disease (CJD) in humans.
Drug-eluting stents (DES) have significantly reduced rates of restenosis compared to their bare metal counterparts and are now increasingly the treatment of choice for percutaneous coronary revascularisations. Despite this, they are not suitable for all cases and anti-platelet therapy can still be r...
Adherent glioma neural stem (GNS) cell lines that retain the characteristics of the original tumour-initiating cells, delivering a powerful model system for chemical and genetic screening.
This cattle‐specific vaccine delivery system can readily deliver and express antigens against a range of diseases that affect cattle, offering the potential to provide long term immunity and protection. It can also be used to deliver therapeutic proteins to improve productivity in cattle.